William Wei-Hwa Leong

This inventor holds 6 USPTO granted patents, plus 4 CIPO patents and 5 EPO patents. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2013-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Wei-Hwa Leong. Retrieved from https://idiyas.com/inventor/william-wei-hwa-leong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 9.4

ph-index = 4

Forward Citations = 47(Granted Patents)

Company Filing History:

6 out of 169

Signal Pharmaceuticals, Inc.

patents

Years Active: 2013-2017

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9827243 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one (2017-11-28),

2. 9403829 - [object Object] (2016-08-02),

3. 9359364 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one (2016-06-07),

4. 9079900 - Methods of synthesis and purification of heteroaryl compounds (2015-07-14),

5. 8686135 - Methods of synthesis and purification of heteroaryl compounds (2014-04-01),

6. 8569494 - Methods of synthesis and purification of heteroaryl compounds (2013-10-29),

Title: The Innovative Contributions of William Wei-Hwa Leong

Introduction

William Wei-Hwa Leong is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of six patents. His work focuses on developing formulations and processes that enhance the efficacy of various compounds.

Latest Patents

Leong's latest patents include innovative pharmaceutical formulations and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one. These formulations aim to provide effective treatments for various diseases and disorders. Another significant patent involves compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, which includes solid forms, isotopologues, and metabolites for therapeutic use.

Career Highlights

Throughout his career, Leong has worked with prominent companies in the pharmaceutical industry, including Signal Pharmaceuticals, Inc. and Celgene Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and delivery.

Collaborations

Leong has collaborated with several professionals in his field, including Matthew Michael Kreilein and Juan Antonio Gamboa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

William Wei-Hwa Leong's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His patents reflect a deep understanding of complex chemical compounds and their applications in treating various conditions.

Profile summary based on public USPTO records.